Clin2
NCT07450716Likely a fitNot yet recruiting

Light therapy for treating itch

Pruritus

Part of Skin clinical trials.

This study tests a light-based therapy (called photobiomodulation) to see if it can reduce itch. The treatment uses a special light on the skin, which may help calm the nerves or cells that cause itching. You'll have one side of your body treated and the other side not, so the researchers can compare the effects.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You must have itch that has lasted less than 6 weeks or more than 6 weeks.
  • You need to have itch on both sides of your body (like both arms or both legs) so the study can compare treated and untreated areas.
  • If you are already using itch treatments, your dose must have been the same for at least 14 days before joining.
  • You cannot have a wound or injury in the area being treated.
  • You cannot be pregnant, breastfeeding, or taking certain medications that make your skin sensitive to light (like doxycycline).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06787794Recruiting
Itch relief using hypnosis and virtual reality

This trial tests whether combining hypnosis with virtual reality can reduce chronic itch. It may help if you have had itching for at least a year, seen a doctor for it, and it still affects your daily life despite treatment.

Leiden, South Holland
NCT05263206Recruiting· Phase 3
Shot medicine (dupilumab) for severe, unexplained chronic itching

This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.

Bakersfield, California
NCT06435299Not yet recruiting· Phase 2
Cannabis-based spray for severe itching that hasn't improved

This study tests whether a cannabis-based oral spray (with equal parts THC and CBD) can safely reduce severe itching when other treatments haven't helped. It compares the spray to an inactive placebo to see if it truly works.

Angers, France
NCT06771375Not yet recruiting
Eye movement therapy for long-term itching

This study tests a type of therapy called EMDR, which uses eye movements to help your brain process feelings, to see if it can reduce chronic itching. If you join, you might find relief from your itch without more pills or creams.

Basel
NCT07236099Recruiting· Phase 2
Study of ICP-332 for prurigo nodularis

This trial tests an experimental drug called ICP-332 for people with prurigo nodularis (a condition causing very itchy, hard bumps on the skin). It aims to see if the drug can safely reduce itching and improve skin lesions.

Birmingham, Alabama
NCT07356362Recruiting
Laser therapy for numbness and itching on the back

This trial tests whether a high-power laser can help relieve the itching, burning, and numbness on one side of the upper back caused by a condition called notalgia paresthetica. It may be an option if you have had these symptoms for at least 3 months and other causes have been ruled out.

Uşak

Hear when a new Pruritus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.